Quentin Bayard

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity.

Journal: Nature communications
Published: October 01, 2024

Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics.

Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics.

Journal: Frontiers in immunology
Published: August 23, 2022

Corrigendum to: 'Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target' [J Hepatol 2021 (74) 1155-1166].

Corrigendum to: 'Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target' [J Hepatol 2021 (74) 1155-1166].

Journal: Journal of hepatology
Published: February 28, 2022

Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.

Bi-allelic hydroxymethylbilane synthase inactivation defines a homogenous clinico-molecular subtype of hepatocellular carcinoma.

Journal: Journal of hepatology
Published: February 02, 2022

Structure, Dynamics, and Impact of Replication Stress-Induced Structural Variants in Hepatocellular Carcinoma.

Structure, Dynamics, and Impact of Replication Stress-Induced Structural Variants in Hepatocellular Carcinoma.

Journal: Cancer research
Published: October 27, 2021

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study.

Journal: The Lancet. Oncology
Published: August 15, 2021

Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer.

Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer.

Journal: Cancer discovery
Published: December 17, 2020

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.

Journal: Genome medicine
Published: November 09, 2020

DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.

DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes.

Journal: Hepatology (Baltimore, Md.)
Published: September 11, 2020

Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.

Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.

Journal: Journal of hepatology
Published: July 03, 2020

Corrigendum to: "BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA" [J Hepatol (2020) 1-13].

Corrigendum to: "BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA" [J Hepatol (2020) 1-13].

Journal: Journal of hepatology
Published: May 04, 2020

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.

BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.

Journal: Journal of hepatology
Published: September 06, 2019
Showing 1-12 of 23

Last Updated: 09/26/2026